Rakotoarison, A.; Kepinska, M.; Konieczny, A.; Władyczak, K.; Janczak, D.; Hałoń, A.; Donizy, P.; Banasik, M.
Endothelin Inhibitors in Chronic Kidney Disease: New Treatment Prospects. J. Clin. Med. 2024, 13, 6056.
https://doi.org/10.3390/jcm13206056
AMA Style
Rakotoarison A, Kepinska M, Konieczny A, Władyczak K, Janczak D, Hałoń A, Donizy P, Banasik M.
Endothelin Inhibitors in Chronic Kidney Disease: New Treatment Prospects. Journal of Clinical Medicine. 2024; 13(20):6056.
https://doi.org/10.3390/jcm13206056
Chicago/Turabian Style
Rakotoarison, Agata, Marta Kepinska, Andrzej Konieczny, Karolina Władyczak, Dariusz Janczak, Agnieszka Hałoń, Piotr Donizy, and Mirosław Banasik.
2024. "Endothelin Inhibitors in Chronic Kidney Disease: New Treatment Prospects" Journal of Clinical Medicine 13, no. 20: 6056.
https://doi.org/10.3390/jcm13206056
APA Style
Rakotoarison, A., Kepinska, M., Konieczny, A., Władyczak, K., Janczak, D., Hałoń, A., Donizy, P., & Banasik, M.
(2024). Endothelin Inhibitors in Chronic Kidney Disease: New Treatment Prospects. Journal of Clinical Medicine, 13(20), 6056.
https://doi.org/10.3390/jcm13206056
